pulmoПульмонологияPULMONOLOGIYA0869-01892541-9617Scientific and Practical Journal “PULMONOLOGIYA” LLC10.18093/0869-0189-2013-0-6-79-84pulmo-312Research ArticleОБЗОРЫREVIEWСовременные возможности коррекции одышки у больных хронической обструктивной болезнью легкихCurrent opportunities to improve dyspnea in patients with chronic obstructive pulmonary diseaseШмелевЕ. И.ShmelevE. I.

д. м. н., профессор, зав. отделом пульмонологии 

107564, Москва, Яузская аллея, 2. Тел.: (499) 785-90-08.

shmelev@mgts.ruГУ "Центральный НИИ туберкулеза РАМН"Russian Federation201328122013067984Copyright © Шмелев Е.И., 20132013Шмелев Е.И.Shmelev E.I.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://journal.pulmonology.ru/pulm/article/view/312

Современные возможности коррекции одышки у больных хронической обструктивной болезнью легких.

Current opportunities to improve dyspnea in patients with chronic obstructive pulmonary disease

хроническая обструктивная болезнь легкиходышкагиперинфляция легких"воздушные ловушки"β2-агонисты длительного действияформотеролэкстрамелкодисперсный аэрозольchronic obstructive pulmonary diseasedyspnealung hyperinflationair trappinglong-acting beta-2-agonistsformoterolextrafine aerosolReferencesAl-Shair K., Mullerova H., Locantore N.W. et al. Fatigue significantly associated with COPD exacerbations: data from the ECLIPSE study. Am. J. Respir. Crit. Care Med. 2011; 183: A3974.Al-Shair K., Mullerova H., Locantore N.W. et al. Fatigue significantly associated with COPD exacerbations: data from the ECLIPSE study. Am. J. Respir. Crit. Care Med. 2011; 183: A3974.Global strategy for diagnosis, management, and prevention of COPD. February 2013.Global strategy for diagnosis, management, and prevention of COPD. February 2013.Чучалин А.Г. (ред.). Руководство по респираторной медицине. М.: ГЭОТАР, 2007; т. 1–2.Чучалин А.Г. (ред.). Руководство по респираторной медицине. М.: ГЭОТАР, 2007; т. 1–2.De Troyer A., Brunko E., Leduc D., Jammes Y. Reflex inhibition of canine inspiratory intercostals by diaphragmatic tension receptors. J. Physiol. (Lond.) 1999; 514 (1): 255–263.De Troyer A., Brunko E., Leduc D., Jammes Y. Reflex inhibition of canine inspiratory intercostals by diaphragmatic tension receptors. J. Physiol. (Lond.) 1999; 514 (1): 255–263.Similowski T., Yan S., Gauthier A.P. et al. Contractile properties of the human diaphragm during chronic hyperinflation. N. Engl. J. Med. 1991; 325: 917–923.Similowski T., Yan S., Gauthier A.P. et al. Contractile properties of the human diaphragm during chronic hyperinflation. N. Engl. J. Med. 1991; 325: 917–923.Tashkin D.P. The role of small airway inflammation in asthma. Allergy Asthma Proc. 2002; 23 (4): 233–242.Tashkin D.P. The role of small airway inflammation in asthma. Allergy Asthma Proc. 2002; 23 (4): 233–242.Hamid Q.A., Mak J.C., Sheppard M.N. et al. Localization of beta-2-adrenoceptor messenger RNA in human and rat lung using in situ hybridization: correlation with receptor autoradiography. Eur. J. Pharmacol. 1991; 206 (2): 133–138.Hamid Q.A., Mak J.C., Sheppard M.N. et al. Localization of beta-2-adrenoceptor messenger RNA in human and rat lung using in situ hybridization: correlation with receptor autoradiography. Eur. J. Pharmacol. 1991; 206 (2): 133–138.Adcock I.M., Gilbey T., Gelder C.M. et al. Glucocorticoid receptor localization in normal and asthmatic lung. Am. J. Respir. Crit. Care Med. 1996; 154 (3, Pt 1): 771–782.Adcock I.M., Gilbey T., Gelder C.M. et al. Glucocorticoid receptor localization in normal and asthmatic lung. Am. J. Respir. Crit. Care Med. 1996; 154 (3, Pt 1): 771–782.Lipworth B.J. Targets for inhaled treatment. Respir. Med. 2000; 94 (Suppl. D): S13–S16.Lipworth B.J. Targets for inhaled treatment. Respir. Med. 2000; 94 (Suppl. D): S13–S16.Tulic M.K., Christodoulopoulos P., Hamid Q. Small airway inflammation in asthma. Respir. Res. 2001; 2 (6): 333–339.Tulic M.K., Christodoulopoulos P., Hamid Q. Small airway inflammation in asthma. Respir. Res. 2001; 2 (6): 333–339.Di Marco F., Milic-Emili J., Boveri B. et al. Effect of inhaled bronchodilators on inspiratory capacity and dyspnoea at rest in COPD. Eur. Respir. J. 2003; 21: 86–94.Di Marco F., Milic-Emili J., Boveri B. et al. Effect of inhaled bronchodilators on inspiratory capacity and dyspnoea at rest in COPD. Eur. Respir. J. 2003; 21: 86–94.Acerbi D., Brambilla G., Kottakis I. Advances in asthma and COPD management: delivering CFC-free inhaled therapy using Modulite technology. Pulm. Pharmacol. Ther. 2007; 20 (3): 290–303.Acerbi D., Brambilla G., Kottakis I. Advances in asthma and COPD management: delivering CFC-free inhaled therapy using Modulite technology. Pulm. Pharmacol. Ther. 2007; 20 (3): 290–303.Criee C.P., Meyer T., Petro W. et al. In vitro comparison of two delivery devices for administering formoterol: Foradil P and formoterol ratiopharm single-dose capsule inhaler. J. Aerosol. Med. 2006; 19 (4): 466–472.Criee C.P., Meyer T., Petro W. et al. In vitro comparison of two delivery devices for administering formoterol: Foradil P and formoterol ratiopharm single-dose capsule inhaler. J. Aerosol. Med. 2006; 19 (4): 466–472.Meyer T., Brand P., Ehlich H. et al. Deposition of Foradil P in human lungs: comparison of in vitro and in vivo data. J. Aerosol. Med. 2004; 17 (1): 43–49.Meyer T., Brand P., Ehlich H. et al. Deposition of Foradil P in human lungs: comparison of in vitro and in vivo data. J. Aerosol. Med. 2004; 17 (1): 43–49.Brand P., Meyer T., Weuthen T. et al. Lung deposition of radiolabeled tiotropium in healthy subjects and patients with chronic obstructive pulmonary disease. J. Clin. Pharmacol. 2007; 47 (10): 1335–1341.Brand P., Meyer T., Weuthen T. et al. Lung deposition of radiolabeled tiotropium in healthy subjects and patients with chronic obstructive pulmonary disease. J. Clin. Pharmacol. 2007; 47 (10): 1335–1341.Haussermann S., Acerbi D., Brand P. et al. Lung deposition of formoterol HFA (Atimos / Forair) in healthy volunteers, asthmatic and COPD patients. J. Aerosol. Med. 2007; 20 (3): 331–341.Haussermann S., Acerbi D., Brand P. et al. Lung deposition of formoterol HFA (Atimos / Forair) in healthy volunteers, asthmatic and COPD patients. J. Aerosol. Med. 2007; 20 (3): 331–341.Terzano C., Petroianni A., Conti V. et al. Rational timing of combination therapy with tiotropium and formoterol in moderate and severe COPD. Respir. Med. 2008; 102 (12): 1701–1707.Terzano C., Petroianni A., Conti V. et al. Rational timing of combination therapy with tiotropium and formoterol in moderate and severe COPD. Respir. Med. 2008; 102 (12): 1701–1707.Tzani P., Crisafulli E., Nicolini G. et al. Effects of beclomethasone / formoterol fixed combination on lung hyperinflation and dyspnea in COPD patients. Int. J. Chron. Obstruct. Pulm. Dis. 2011; 6: 503–509.Tzani P., Crisafulli E., Nicolini G. et al. Effects of beclomethasone / formoterol fixed combination on lung hyperinflation and dyspnea in COPD patients. Int. J. Chron. Obstruct. Pulm. Dis. 2011; 6: 503–509.

The authors declare that there are no conflicts of interest present.